|
| Figure 2: Beneficial pathways of dietary composition (omega 6/omega 3 ratio) in the nutritional treatment and prevention of NAFLD. PPAR (proliferator-activated receptor), SREBP-1 (sterol regulatory element binding protein-1), VDR (Vitamin D Receptor), COX (cyclooxygenase), LOX (lipoxygenase), NFκB (nuclear factor kappa B), IκB-α (nuclear factor – kappa-B inhibitor alpha), IL-1β (Interleukin-1 beta), TNF- α (tumor of necrosis factor alpha). |
